middle.news
How Noxopharm’s HERACLES Trial Success Could Transform Autoimmune Treatment
9:18am on Friday 30th of January, 2026 AEDT
•
Biotechnology
Read Story
How Noxopharm’s HERACLES Trial Success Could Transform Autoimmune Treatment
9:18am on Friday 30th of January, 2026 AEDT
Key Points
HERACLES trial dosing successfully completed with positive safety results
New Material Transfer Agreement signed with overseas partner for autoimmune therapeutics
First US patent granted for Sofra immune-modulatory oligonucleotides
Victorian Government recognition highlights strategic collaboration
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NOXOPHARM (ASX:NOX)
OPEN ARTICLE